HOME >> MEDICINE >> NEWS
Baltimore researchers receive $40 million from Bill & Melinda Gates Foundation

Johns Hopkins School of Public Health and University of Maryland School of Medicine to develop ground-breaking measles vaccine for infants in developing countries

The Bill & Melinda Gates Foundation has awarded grants of $20 million each to the University of Maryland School of Medicine and the Johns Hopkins University School of Public Health to develop a new type of measles vaccine that, for the first time, would protect infants younger than 9 months old. Such a vaccine would dramatically reduce the suffering and death rate from measles in developing countries.

"Finding a safe and effective vaccine to protect the world's youngest children against measles is an urgent global health priority," says Bill Foege, Senior Health Advisor at the Bill & Melinda Gates Foundation. "We are tremendously hopeful that this collaboration between two major research facilities will speed the development of this important vaccine and ultimately help save millions of children's lives."

Measles kills more than 900,000 children each year in less developed parts of the world, according to the World Health Organization (WHO). While widespread use of the current injected measles vaccine has saved the lives of millions of children, the disease is far from being eradicated in the developing world because a window of vulnerability exists among infants from 5 to 8 months of age.

Newborns are protected against measles by antibodies passed to them from their mothers, but those antibody levels drop steadily over time, increasing the infants' susceptibility to measles. At the same time, low levels of the mother's antibodies neutralize the effectiveness of the measles vaccine. For that reason, the WHO recommends that the current measles vaccine be administered when children are at least 9 months old.

"We are pleased that the Bill & Melinda Gates Foundation has asked us to take on this ambitious, five-year project. It will involve laboratory work as well as cl
'"/>

Contact: Dennis O'Shea
dro@jhu.edu
410-516-7109
Johns Hopkins University
27-Aug-2000


Page: 1 2 3 4

Related medicine news :

1. Impact of 2002 Canadian forest fires felt 700 miles away in Baltimore, Maryland
2. HIV infection rate and risky behavior decline amoung injection drug users in Baltimore
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Protein that helps skin cancer spread identified by Stanford researchers
5. US life expectancy about to decline, researchers say
6. Gene for age-related macular degeneration discovered by Yale researchers
7. Dartmouth researchers find where musical memories are stored in the brain
8. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
9. US cancer researchers launch first American-Israeli cancer conference
10. USC dental researchers develop first test for predicting cavities in children
11. Young blood revives aging muscles, Stanford researchers find

Post Your Comments:
(Date:8/4/2015)... ... August 04, 2015 , ... In ... filed against Johnson & Johnson report that a new location for pretrial proceedings ... regular news updates and cancer warning information at their website, the Talcum Powder ...
(Date:8/4/2015)... ... August 04, 2015 , ... Nathan’s Famous was recently ... small, medium, and large businesses making an impact in their industry. Andrew Tropeano, the ... how the famous hot dog maker now offers a 50% Reduced Fat All-Beef ...
(Date:8/4/2015)... Palm Coast, Florida (PRWEB) , ... August 04, ... ... Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction ... Prevention and DVT/PE." The activity is jointly provided by Medical Learning Institute Inc. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Please join us for the ... Sunday, September 20th at Oneida Shores Park in Brewerton, NY. , Doris Connor ... brain aneurysm at the young age of 59. Her family and friends have since ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... a state-of-the-art digital press at its Denver facility that will usher in a ... will help Lightning Labels more effectively meet its twin objectives of ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3
(Date:8/3/2015)... 3, 2015  CytRx Corporation (NASDAQ: CYTR ), ... today reported financial results for the three months ended ... recent accomplishments and upcoming milestones for its clinical development ... been very productive for CytRx. Enrollment in our ongoing ... soft tissue sarcoma (STS) continues on track to be ...
(Date:8/3/2015)... Colo., Aug. 3, 2015  Array BioPharma Inc. ... the fourth quarter and full year of its ... Ron Squarer, Chief Executive Officer of Array, noted, "Binimetinib ... 3, are on track for regulatory submissions in ... BRAF-mutant melanoma and BRAF-mutant colorectal cancer further validate ...
(Date:8/3/2015)... 2015 Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: ... Teper , will present live at VirtualInvestorConferences.com on August ...   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... where investors are invited to ask the company questions ... well as the association,s "virtual trade booth." If attendees ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
Cached News: